Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Calvert

Showing results (81-90 of 220) with videos related to

Pageof 22
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1991
The pharmacokinetics of the quinazoline antifolate ICI D 1694 in mice and ratsD I Jodrell, D R Newell, W Gibson, et al.
British Journal of Cancer|May 1, 1995
Molecular characterisation of two cell lines selected for resistance to the folate-based thymidylate synthase inhibitor, ZD1694S J Freemantle, A L Jackman, L R Kelland, et al.
Journal of Medicinal Chemistry|March 6, 1992
Syntheses and thymidylate synthase inhibitory activity of the poly-gamma-glutamyl conjugates of N-[5-[N-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino ]-2-thenoyl]-L-glutamic acid (ICI D1694) and other quinazoline antifolatesG M Bisset, K Pawelczak, A L Jackman, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 17, 2006
Mechanisms of early brain injury after subarachnoid hemorrhageJulian Cahill, W Julian Cahill, John W Calvert, et al.
Cancer Treatment Reports|November 1, 1983
Phase II study of JM8, a new platinum analog, in advanced ovarian carcinomaB D Evans, K S Raju, A H Calvert, et al.
Anti-Cancer Drug Design|March 1, 1989
Quinazoline antifolates inhibiting thymidylate synthase: computer modelling of the N10 substituentT R Jones, R F Betteridge, S Neidle, et al.
Seminars in Oncology|December 22, 1999
Prevention of thymidine and hypoxanthine rescue from MTA (LY231514) growth inhibition by dipyridamole in human lung cancer cell linesP G Smith, E Marshman, A H Calvert, et al.
Cancer Treatment Reviews|September 1, 1985
Phase I studies with carboplatin at the Royal Marsden HospitalA H Calvert, S J Harland, D R Newell, et al.
Journal of Environmental Quality|January 12, 2007
Aerating grasslands: effects on runoff and phosphorus losses from applied broiler litterD H Franklin, M L Cabrera, L T West, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
Activity of the dolastatin analogue, LU103793, in malignant melanomaJ Smyth, M E Boneterre, J Schellens, et al.
Pageof 22

Showing results (81-90 of 220) with videos related to

Sort By:
Pageof 22
Cancer Chemotherapy and Pharmacology|January 1, 1991
The pharmacokinetics of the quinazoline antifolate ICI D 1694 in mice and ratsD I Jodrell, D R Newell, W Gibson, et al.
British Journal of Cancer|May 1, 1995
Molecular characterisation of two cell lines selected for resistance to the folate-based thymidylate synthase inhibitor, ZD1694S J Freemantle, A L Jackman, L R Kelland, et al.
Journal of Medicinal Chemistry|March 6, 1992
Syntheses and thymidylate synthase inhibitory activity of the poly-gamma-glutamyl conjugates of N-[5-[N-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino ]-2-thenoyl]-L-glutamic acid (ICI D1694) and other quinazoline antifolatesG M Bisset, K Pawelczak, A L Jackman, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 17, 2006
Mechanisms of early brain injury after subarachnoid hemorrhageJulian Cahill, W Julian Cahill, John W Calvert, et al.
Cancer Treatment Reports|November 1, 1983
Phase II study of JM8, a new platinum analog, in advanced ovarian carcinomaB D Evans, K S Raju, A H Calvert, et al.
Anti-Cancer Drug Design|March 1, 1989
Quinazoline antifolates inhibiting thymidylate synthase: computer modelling of the N10 substituentT R Jones, R F Betteridge, S Neidle, et al.
Seminars in Oncology|December 22, 1999
Prevention of thymidine and hypoxanthine rescue from MTA (LY231514) growth inhibition by dipyridamole in human lung cancer cell linesP G Smith, E Marshman, A H Calvert, et al.
Cancer Treatment Reviews|September 1, 1985
Phase I studies with carboplatin at the Royal Marsden HospitalA H Calvert, S J Harland, D R Newell, et al.
Journal of Environmental Quality|January 12, 2007
Aerating grasslands: effects on runoff and phosphorus losses from applied broiler litterD H Franklin, M L Cabrera, L T West, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
Activity of the dolastatin analogue, LU103793, in malignant melanomaJ Smyth, M E Boneterre, J Schellens, et al.
Pageof 22